Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Details Narrative)

v3.19.3
Loss Per Share (Details Narrative) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Options and warrants outstanding to acquire shares of common stock 2,900,000   2,900,000   2,980,000
Common Stock Equivalents [Member]          
Common stock equivalent and options excluded from earnings (loss) per share computation as anti-dilutive effect 2,900,000 2,800,000 2,900,000 2,800,000